InnovHeart rallies $55m Series C

InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised $55 million in Series C financing.

28 January 2022•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles